Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized dose-ranging study of samidorphan with olanzapine in adults with schizophrenia
2013-002193-45Phase 2Completed
- Sponsor
- Alkermes
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of olanzapine + samidorphan in schizophrenia (3 arms), sponsored by Alkermes. Started Oct 2013; status: completed.
02
Drugs
olanzapine + samidorphan
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2013-002193-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002193-45.